These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

222 related items for PubMed ID: 36562783

  • 1. Quantitative susceptibility mapping of the normal-appearing white matter as a potential new marker of disability progression in multiple sclerosis.
    Pietroboni AM, Colombi A, Contarino VE, Russo FML, Conte G, Morabito A, Siggillino S, Carandini T, Fenoglio C, Arighi A, De Riz MA, Arcaro M, Sacchi L, Fumagalli GG, Bianchi AM, Triulzi F, Scarpini E, Galimberti D.
    Eur Radiol; 2023 Aug; 33(8):5368-5377. PubMed ID: 36562783
    [Abstract] [Full Text] [Related]

  • 2. Quantitative susceptibility mapping of both ring and non-ring white matter lesions in relapsing remitting multiple sclerosis.
    Coffman CH, White R, Subramanian K, Buch S, Bernitsas E, Haacke EM.
    Magn Reson Imaging; 2022 Sep; 91():45-51. PubMed ID: 35605736
    [Abstract] [Full Text] [Related]

  • 3. Amyloid PET as a marker of normal-appearing white matter early damage in multiple sclerosis: correlation with CSF β-amyloid levels and brain volumes.
    Pietroboni AM, Carandini T, Colombi A, Mercurio M, Ghezzi L, Giulietti G, Scarioni M, Arighi A, Fenoglio C, De Riz MA, Fumagalli GG, Basilico P, Serpente M, Bozzali M, Scarpini E, Galimberti D, Marotta G.
    Eur J Nucl Med Mol Imaging; 2019 Feb; 46(2):280-287. PubMed ID: 30343433
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Normal appearing white matter permeability: a marker of inflammation and information processing speed deficit among relapsing remitting multiple sclerosis patients.
    Eftekhari E, Hojjat SP, Vitorino R, Carroll TJ, Cantrell CG, Lee L, Taylor MW, Morrow SA, Benhabib H, Aviv RI, Kassner A.
    Neuroradiology; 2017 Aug; 59(8):771-780. PubMed ID: 28623483
    [Abstract] [Full Text] [Related]

  • 13. Characterization of normal-appearing white matter in multiple sclerosis using quantitative susceptibility mapping in conjunction with diffusion tensor imaging.
    Yu FF, Chiang FL, Stephens N, Huang SY, Bilgic B, Tantiwongkosi B, Romero R.
    Neuroradiology; 2019 Jan; 61(1):71-79. PubMed ID: 30539215
    [Abstract] [Full Text] [Related]

  • 14. Microstructural alterations in different types of lesions and their perilesional white matter in relapsing-remitting multiple sclerosis based on diffusion kurtosis imaging.
    Shi Z, Pan Y, Yan Z, Ding S, Hu H, Wei Y, Luo D, Xu Y, Zhu Q, Li Y.
    Mult Scler Relat Disord; 2023 Mar; 71():104572. PubMed ID: 36821979
    [Abstract] [Full Text] [Related]

  • 15. Non-lesional white matter changes depicted by q-space diffusional MRI correlate with clinical disabilities in multiple sclerosis.
    Motegi H, Kufukihara K, Kitagawa S, Sekiguchi K, Hata J, Fujiwara H, Jinzaki M, Okano H, Nakamura M, Iguchi Y, Nakahara J.
    J Neurol Sci; 2024 Jan 15; 456():122851. PubMed ID: 38181653
    [Abstract] [Full Text] [Related]

  • 16. Quantifying Remyelination Using χ-Separation in White Matter and Cortical Multiple Sclerosis Lesions.
    Müller J, Lu PJ, Cagol A, Ruberte E, Shin HG, Ocampo-Pineda M, Chen X, Tsagkas C, Barakovic M, Galbusera R, Weigel M, Schaedelin SA, Wang Y, Nguyen TD, Spincemaille P, Kappos L, Kuhle J, Lee J, Granziera C.
    Neurology; 2024 Sep 24; 103(6):e209604. PubMed ID: 39213476
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Fingolimod treatment reverses signs of diffuse white matter damage in multiple sclerosis: A pilot study.
    Saraste M, Bezukladova S, Sucksdorff M, Saunavaara V, Rissanen E, Matilainen M, Airas L.
    Mult Scler Relat Disord; 2021 Feb 24; 48():102690. PubMed ID: 33352357
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.